CLINICAL AND ECHOCARDIOGRAPHIC FEATURES OF SEVERE CONGESTIVE-HEART-FAILURE ACCORDING TO DIFFERENT PATHOGENETIC MECHANISM

被引:0
作者
FAGGIANO, P [1 ]
RUSCONI, C [1 ]
GHIZZONI, G [1 ]
SABATINI, T [1 ]
SORGATO, A [1 ]
SIMONCELLI, U [1 ]
机构
[1] ST ORSOLA HOSP,CORONARY CARE UNIT,I-25133 BRESCIA,ITALY
来源
ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY | 1992年 / 4卷 / 04期
关键词
DIASTOLIC DYSFUNCTION; CONGESTIVE HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure (CHF) may be caused by systolic dysfunction (SD) of the left ventricle (LV) or isolated diastolic dysfunction (DD). Differentiation between SD and DD is important because each one requires a different form of therapy. In order to evaluate if some clinical and/or echocardiographic differences exist between patients(pts) with CHF from SD or DD we have analysed a group of 120 pts admitted to our Division with severe CHF (NYHA III-IV). After clinical evaluation all pts underwent a complete Echo-Doppler examination at the time of admission. SD was considered present if LV end-diastolic diameter (LVEDD) greater-than-or-equal-to 56 mm and LV fractional shortening (FS %) < 25%. DD was considered present if LVEDD and FS were both within a normal range. Furthermore, wall thickness and LV filling by Doppler Transmitral flow during early filling (Evel) and atrial contraction (Avel) were measured. Results: CHF was caused by SD in 90 pts (75%) and by DD in 30 pts (25%), p < 0.001. SD was due to dilated cardiomyopathy (83 pts), ischemic or idiopathic, and to severe aortic stenosis (7 pts); DD was due to aortic stenosis (20 pts), hypertrophic cardiomyopathy (4 pts) and hypertensive cardiopathy (6 pts).
引用
收藏
页码:309 / 314
页数:6
相关论文
共 50 条
  • [41] NEBIVOLOL INCREASES SURVIVAL IN CARDIOMYOPATHIC HAMSTERS WITH CONGESTIVE-HEART-FAILURE
    DONCK, LV
    WOUTERS, L
    OLBRICH, HG
    MUTSCHLER, E
    BORGERS, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (01) : 1 - 3
  • [42] BENEFICIAL EFFECT OF ACE-INHIBITOR IN CONGESTIVE-HEART-FAILURE
    TAKEDA, N
    TANAMURA, A
    IWAI, T
    KATO, M
    NOMA, K
    NAGANO, M
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 129 (02) : 139 - 143
  • [43] EFFECT OF NEUTRAL ENDOPEPTIDASE INHIBITOR IN RATS WITH CONGESTIVE-HEART-FAILURE
    MUROHARA, Y
    JOHNSTON, CI
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, 19 (05) : 380 - 383
  • [44] ELEVATED CONCENTRATIONS OF ENDOGENOUS OUABAIN IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
    GOTTLIEB, SS
    ROGOWSKI, AC
    WEINBERG, M
    KRICHTEN, CM
    HAMILTON, BP
    HAMLYN, JM
    CIRCULATION, 1992, 86 (02) : 420 - 425
  • [45] ACE INHIBITORS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE AND RENAL DYSFUNCTION
    HEIDLAND, A
    TESCHNER, M
    GOTZ, R
    KLINISCHE WOCHENSCHRIFT, 1991, 69 : 65 - 74
  • [46] INFLUENCE OF CONGESTIVE-HEART-FAILURE ON ENDOTHELIN LEVELS AND RECEPTORS IN RABBITS
    LOFFLER, BM
    ROUX, S
    KALINA, B
    CLOZEL, M
    CLOZEL, JP
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (04) : 407 - 416
  • [47] INTRALOBAR PULMONARY SEQUESTRATION IN A NEWBORN PRESENTING CONGESTIVE-HEART-FAILURE
    KOSKAS, M
    BALQUET, P
    TOURNIER, G
    JUST, J
    SARDET, A
    REVUE DES MALADIES RESPIRATOIRES, 1991, 8 (02) : 242 - 245
  • [48] CONGESTIVE-HEART-FAILURE CAUSED BY VITAMIN-D DEFICIENCY
    BRUNVAND, L
    HAGA, P
    TANGSRUD, SE
    HAUG, E
    ACTA PAEDIATRICA, 1995, 84 (01) : 106 - 108
  • [49] PLASMA-LEVELS OF CYCLIC-NUCLEOTIDES IN CHRONIC CONGESTIVE-HEART-FAILURE AND THEIR CLINICAL IMPLICATION
    ZHENG, X
    MA, SJ
    ZHANG, TH
    CHEN, SC
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1993, 40 (01) : 7 - 15
  • [50] HEMODYNAMIC-RESULTS AFTER ACUTE ADMINISTRATION OF AMRINONE AND ENOXIMONE IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
    SABOROWSKI, F
    PETERS, P
    SCHNEIDER, M
    ZEITSCHRIFT FUR KARDIOLOGIE, 1991, 80 : 63 - 67